Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Surmodics, Inc. (SRDX) had Stock-Based Compensation of $7.61M for the most recently reported fiscal year, ending 2023-09-30.
Income Statement Financials | |
$132.58M |
|
$-1.54M |
|
$24.96M |
|
$107.62M |
|
$127.43M |
|
$5.15M |
|
$-2.66M |
|
$2.49M |
|
$2.49M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$5.15M |
|
$14.04M |
|
14.03M |
|
14.03M |
|
$-0.11 |
|
$-0.11 |
|
Balance Sheet Financials | |
$86.69M |
|
$26.03M |
|
$99.04M |
|
$185.73M |
|
$23.95M |
|
$29.41M |
|
$41.87M |
|
$65.82M |
|
$119.91M |
|
$50.76M |
|
$119.91M |
|
14.15M |
|
Cash Flow Statement Financials | |
$10.51M |
|
$-6.82M |
|
$18.41M |
|
$19.00M |
|
$41.42M |
|
$22.42M |
|
Stock-Based Compensation |
$7.61M |
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
3.62 |
|
-- |
|
-- |
|
0.20 |
|
0.25 |
|
81.17% |
|
3.88% |
|
3.88% |
|
10.59% |
|
1.88% |
|
-1.16% |
|
$7.60M |
|
-- |
|
-- |
|
-- |
|
0.71 |
|
1.68 |
|
11.69 |
|
31.22 |
|
-1.28% |
|
-3.03% |
|
-0.83% |
|
-1.03% |
|
$8.47 |
|
$0.54 |
|
$0.75 |